Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.76 USD | -1.47% | +4.92% | -13.12% |
05-07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
05-07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.12% | 1.9B | |
+33.43% | 49.46B | |
+1.83% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.72% | 26.61B | |
-21.81% | 18.64B | |
+7.91% | 13.16B | |
+29.53% | 12.55B | |
+23.78% | 12.1B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- RBC Cuts Price Target on Beam Therapeutics to $42 From $50, Maintains Sector Perform, Speculative Risk Rating